Safety of Anthracyclines in Breast Cancer Patients with Glucose-6-Phosphate Dehydrogenase Deficiency

Objective: To examine the safety of doxorubicin and epirubicin in breast cancer patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Material and Methods: A retrospective cohort study was conducted at a single oncology center. Patients with breast cancer and G6PD deficiency, who recei...

Full description

Bibliographic Details
Published in:Journal of Oncological Sciences
Main Authors: Zeki SÜRMELİ, Nawaf Mohammed ALKHALFAN, Fatima FAQIHI, Fahir ÖZTÜRK, Çiğdem Pala ÖZTÜRK
Format: Article
Language:English
Published: Turkish Society of Oncology 2025-08-01
Subjects:
g6pd deficiency
hemolysis
anthracycline
epirubicin
doxorubicin
breast neoplasms
Online Access:https://journalofoncology.org/articles/safety-of-anthracyclines-in-breast-cancer-patients-with-glucose-6-phosphate-dehydrogenase-deficiency/doi/jos.galenos.2025.2025-3-10

Internet

https://journalofoncology.org/articles/safety-of-anthracyclines-in-breast-cancer-patients-with-glucose-6-phosphate-dehydrogenase-deficiency/doi/jos.galenos.2025.2025-3-10

Similar Items